Cargando…
Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin
Antibody‐mediated graft rejection caused by donor‐specific antibodies (DSA‐MR) remains a serious problem after heart transplantation (HTx). IgM‐enriched human intravenous immunoglobulin (IGM‐IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and provides a new multifactorial approach for DSA‐MR. Betwee...
Autores principales: | Immohr, Moritz Benjamin, Akhyari, Payam, Aubin, Hug, Westenfeld, Ralf, Mehdiani, Arash, Bruno, Raphael Romano, Sipahi, Nihat Firat, Erbel‐Khurtsidze, Sophiko, Reinecke, Petra, Tudorache, Igor, Lichtenberg, Artur, Boeken, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318410/ https://www.ncbi.nlm.nih.gov/pubmed/33969938 http://dx.doi.org/10.1002/ehf2.13409 |
Ejemplares similares
-
Heart Transplantation of the Elderly—Old Donors for Old Recipients: Can We Still Achieve Acceptable Results?
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022) -
Impact of pretransplant left ventricular assist device support duration on outcome after heart transplantation
por: Immohr, Moritz Benjamin, et al.
Publicado: (2021) -
Adequate immune response after SARS‐CoV‐2 infection and single dose vaccination despite rapid heart transplantation
por: Erbel‐Khurtsidze, Sophiko, et al.
Publicado: (2021) -
Initial experience covering 50 consecutive cases of large Impella implantation at a single heart centre
por: Sugimura, Yukiharu, et al.
Publicado: (2021) -
IgM‐enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices
por: Immohr, Moritz Benjamin, et al.
Publicado: (2022)